![](/img/cover-not-exists.png)
Successful treatment of severe psoriasis relapse with Secukinumab(IL17 A inhibitor) after abrupt Brodalumab (IL17 receptor inhibitor) discontinuation: A retrospective study evaluating long term efficacy and safety
Khemis, Abdallah, Kelati, Awatef, Montaudié, Henri, Lacour, Jean-Philippe, Passeron, ThierryLanguage:
english
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2018.03.027
Date:
March, 2018
File:
PDF, 353 KB
english, 2018